ORANGE, Calif., Nov. 6 Metrex Research Corporationintroduces MetriCide OPA Plus(TM) Solution, a new high-level disinfectant tocomplement the company's industry-leading line of ...
ORANGE, Calif.--(BUSINESS WIRE)--The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective ...
Vomaris Innovations announced an agreement to have Metrex become the exclusive global commercial partner for distribution of its Procellera Antimicrobial Wound Dressings. The dressings use technology ...
Patients with chronic obstructive pulmonary disease (COPD) with an eosinophilic phenotype may benefit from treatment with mepolizumab, a monoclonal antibody directed against interleukin-5. We ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Two pivotal ...
Vomaris Innovations, Inc. announced today that it has entered into an exclusive global commercial partnership for its microcurrent generating wound care products, Procellera® Antimicrobial Wound ...
Please provide your email address to receive an email when new articles are posted on . Dupilumab and mepolizumab are the only FDA-approved biologics for adults with COPD and an eosinophilic phenotype ...
Healthcare facilities increasingly use very aggressive disinfectants to combat healthcare-acquired infections (HAIs) in general and, currently, to prevent spread of the SARS-CoV-2 virus. Medical ...
ORANGE, Calif.--(BUSINESS WIRE)-- The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback